Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison
Crespo-Facorro et al.
J Psychopharmacol 2011;25:744-754.
ABSTRACT
| FULL TEXT
Subjective Well-Being in Schizophrenia as Measured with the Subjective Well-Being Under Neuroleptic Treatment Scale: A Review
Vothknecht et al.
Aust N Z J Psychiatry 2011;45:182-192.
ABSTRACT
| FULL TEXT
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders
Liew et al.
J Psychopharmacol 2010;24:973-980.
ABSTRACT
To Medicate Or Not to Medicate, When Diagnosis Is In Question: Decision-Making in First Episode Psychosis
Malhi et al.
Australas Psychiatry 2010;18:230-237.
ABSTRACT
| FULL TEXT
Effect of Treatment on Weight Gain and Metabolic Abnormalities in Patients with First-Episode Psychosis
Verma et al.
Aust N Z J Psychiatry 2009;43:812-817.
ABSTRACT
| FULL TEXT
Effects of Second-Generation Antipsychotic Medication on Smooth Pursuit Performance in Antipsychotic-Naive Schizophrenia
Lencer et al.
Arch Gen Psychiatry 2008;65:1146-1154.
ABSTRACT
| FULL TEXT
Oculomotor and Neuropsychological Effects of Antipsychotic Treatment for Schizophrenia
Hill et al.
Schizophr Bull 2008;34:494-506.
ABSTRACT
| FULL TEXT
Has Research Informed Us on the Practical Drug Treatment of Schizophrenia?
Davis and Leucht
Schizophr Bull 2008;34:403-405.
FULL TEXT
Insight and treatment attitude in schizophrenia: comparison of patients on depot and atypical antipsychotics
Mahadun and Marshall
The Psychiatrist 2008;32:53-56.
ABSTRACT
| FULL TEXT
How CATIE brought us back to Kansas: a critical re-evaluation of the concept of atypical antipsychotics and their place in the treatment of schizophrenia
Owens
Adv. Psychiatr. Treat. 2008;14:17-28.
ABSTRACT
| FULL TEXT
Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
Reilly et al.
Arch Gen Psychiatry 2006;63:1189-1197.
ABSTRACT
| FULL TEXT
Rational pharmacotherapy in early psychosis
REMINGTON
Br. J. Psychiatry 2005;187:s77-s84.
ABSTRACT
| FULL TEXT
Clinical Outcome of an Early Psychosis Intervention Program: Evaluation in a Real-World Context
Nash et al.
Aust N Z J Psychiatry 2004;38:694-701.
ABSTRACT
| FULL TEXT
Delayed Onset of Oculogyric Crisis and Torticollis with Intramuscular Haloperidol
Jhee et al.
The Annals of Pharmacotherapy 2003;37:1434-1437.
ABSTRACT
| FULL TEXT
Origins of Early Intervention in First-Episode Psychosis
Sanbrook and Harris
Australas Psychiatry 2003;11:215-219.
ABSTRACT
| FULL TEXT
Determining the optimal dose of haloperidol in first-episode psychosis
Oosthuizen et al.
J Psychopharmacol 2001;15:251-255.
ABSTRACT
Low dose typical antipsychotics -- a brief evaluationAuthor's reply
Oosthuizen et al.
The Psychiatrist 2001;25:194-194.
FULL TEXT
Antipsychotic Drugs: Importance of Dopamine Receptors for Mechanisms of Therapeutic Actions and Side Effects
Strange
Pharmacol. Rev. 2001;53:119-134.
ABSTRACT
| FULL TEXT
Low dose typical antipsychotics - a brief evaluation
Taylor
The Psychiatrist 2000;24:465-468.
FULL TEXT
Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses
TURKINGTON and KINGDON
Br. J. Psychiatry 2000;177:101-106.
ABSTRACT
| FULL TEXT
Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics
Yorston and Pinney
The Psychiatrist 2000;24:130-132.
ABSTRACT
| FULL TEXT
Optimal Treatment Strategies to Enhance Recovery from Schizophrenia
Falloon et al.
Aust N Z J Psychiatry 1998;32:43-49.
ABSTRACT
Neuroleptic Management of Schizophrenia: A Survey and Commentary on Australian Psychiatric Practice
Parker et al.
Aust N Z J Psychiatry 1998;32:50-58.
ABSTRACT
Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials
Fujian Song
J Psychopharmacol 1997;11:65-71.
ABSTRACT
Clinical Risk Following Abrupt and Gradual Withdrawal of Maintenance Neuroleptic Treatment
Viguera et al.
Arch Gen Psychiatry 1997;54:49-55.
ABSTRACT
Drug Strategies and Treatment-Resistant Schizophrenia
Pantelis and Barnes
Aust N Z J Psychiatry 1996;30:20-37.
ABSTRACT
Plasma Haloperidol Levels and Clinical Effects in Schizophrenia and Schizoaffective Disorder
Volavka et al.
Arch Gen Psychiatry 1995;52:837-845.
ABSTRACT
Early Detection of Neuroleptic-Induced Parkinsonism in Elderly Patients with Dementia
Sweet et al.
J Geriatr Psychiatry Neurol 1994;7:251-253.
ABSTRACT
Lower-Dose Therapy With Traditional Neuroleptics in Chronically Hospitalized Schizophrenic Patients
Smith
Arch Gen Psychiatry 1994;51:427-429.
ABSTRACT
